Soligenix extends patent protection for its Filovirus vaccine to United Kingdom and South Africa

Soligenix, Inc, a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced that it has received notice of intent to grant additional patents based on its …
Soligenix extends patent protection for its Filovirus vaccine to United Kingdom and South Africa